A House Appropriations subcommittee advanced its fiscal 2024 spending bill for the Food and Drug Agency on Thursday, sneaking in a provision that would reverse the agency’s decision to allow the abortion pill mifepristone to be delivered by mail.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
